Literature DB >> 26072729

Synthesis of 2-deoxy-2,2-difluoro-α-maltosyl fluoride and its X-ray structure in complex with Streptomyces coelicolor GlgEI-V279S.

Sandeep Thanna1, Jared J Lindenberger, Vishwanath V Gaitonde, Donald R Ronning, Steven J Sucheck.   

Abstract

Streptomyces coelicolor (Sco) GlgEI is a glycoside hydrolase involved in α-glucan biosynthesis and can be used as a model enzyme for structure-based inhibitor design targeting Mycobacterium tuberculosis (Mtb) GlgE. The latter is a genetically validated drug target for the development of anti-Tuberculosis (TB) treatments. Inhibition of Mtb GlgE results in a lethal buildup of the GlgE substrate maltose-1-phosphate (M1P). However, Mtb GlgE is difficult to crystallize and affords lower resolution X-ray structures. Sco GlgEI-V279S on the other hand crystallizes readily, produces high resolution X-ray data, and has active site topology identical to Mtb GlgE. We report the X-ray structure of Sco GlgEI-V279S in complex with 2-deoxy-2,2-difluoro-α-maltosyl fluoride (α-MTF, 5) at 2.3 Å resolution. α-MTF was designed as a non-hydrolysable mimic of M1P to probe the active site of GlgE1 prior to covalent bond formation without disruption of catalytic residues. The α-MTF complex revealed hydrogen bonding between Glu423 and the C1F which provides evidence that Glu423 functions as proton donor during catalysis. Further, hydrogen bonding between Arg392 and the axial C2 difluoromethylene moiety of α-MTF was observed suggesting that the C2 position tolerates substitution with hydrogen bond acceptors. The key step in the synthesis of α-MDF was transformation of peracetylated 2-fluoro-maltal 1 into peracetylated 2,2-difluoro-α-maltosyl fluoride 2 in a single step via the use of Selectfluor®.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26072729      PMCID: PMC4489993          DOI: 10.1039/c5ob00867k

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  14 in total

1.  Structure of Streptomyces maltosyltransferase GlgE, a homologue of a genetically validated anti-tuberculosis target.

Authors:  Karl Syson; Clare E M Stevenson; Martin Rejzek; Shirley A Fairhurst; Alap Nair; Celia J Bruton; Robert A Field; Keith F Chater; David M Lawson; Stephen Bornemann
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

2.  Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway.

Authors:  Rainer Kalscheuer; Karl Syson; Usha Veeraraghavan; Brian Weinrick; Karolin E Biermann; Zhen Liu; James C Sacchettini; Gurdyal Besra; Stephen Bornemann; William R Jacobs
Journal:  Nat Chem Biol       Date:  2010-03-21       Impact factor: 15.040

3.  Mechanism-based inhibition of yeast alpha-glucosidase and human pancreatic alpha-amylase by a new class of inhibitors. 2-Deoxy-2,2-difluoro-alpha-glycosides.

Authors:  C Braun; G D Brayer; S G Withers
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

4.  Synthesis and testing of 2-deoxy-2,2-dihaloglycosides as mechanism-based inhibitors of alpha-glycosidases.

Authors:  Ran Zhang; John D McCarter; Curtis Braun; Wai Yeung; Gary D Brayer; Stephen G Withers
Journal:  J Org Chem       Date:  2008-03-18       Impact factor: 4.354

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Towards automated crystallographic structure refinement with phenix.refine.

Authors:  Pavel V Afonine; Ralf W Grosse-Kunstleve; Nathaniel Echols; Jeffrey J Headd; Nigel W Moriarty; Marat Mustyakimov; Thomas C Terwilliger; Alexandre Urzhumtsev; Peter H Zwart; Paul D Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2012-03-16

7.  Synthesis of fluorinated maltose derivatives for monitoring protein interaction by (19)F NMR.

Authors:  Michaela Braitsch; Hanspeter Kählig; Georg Kontaxis; Michael Fischer; Toshinari Kawada; Robert Konrat; Walther Schmid
Journal:  Beilstein J Org Chem       Date:  2012-03-27       Impact factor: 2.883

8.  Structural insight into how Streptomyces coelicolor maltosyl transferase GlgE binds α-maltose 1-phosphate and forms a maltosyl-enzyme intermediate.

Authors:  Karl Syson; Clare E M Stevenson; Abdul M Rashid; Gerhard Saalbach; Minhong Tang; Anne Tuukkanen; Dmitri I Svergun; Stephen G Withers; David M Lawson; Stephen Bornemann
Journal:  Biochemistry       Date:  2014-04-11       Impact factor: 3.162

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

Review 10.  Dissecting conformational contributions to glycosidase catalysis and inhibition.

Authors:  Gaetano Speciale; Andrew J Thompson; Gideon J Davies; Spencer J Williams
Journal:  Curr Opin Struct Biol       Date:  2014-07-10       Impact factor: 6.809

View more
  10 in total

1.  Zwitterionic pyrrolidene-phosphonates: inhibitors of the glycoside hydrolase-like phosphorylase Streptomyces coelicolor GlgEI-V279S.

Authors:  Sri Kumar Veleti; Cecile Petit; Donald R Ronning; Steven J Sucheck
Journal:  Org Biomol Chem       Date:  2017-05-10       Impact factor: 3.876

Review 2.  Designing sugar mimetics: non-natural pyranosides as innovative chemical tools.

Authors:  Regis C Saliba; Nicola Lb Pohl
Journal:  Curr Opin Chem Biol       Date:  2016-09-10       Impact factor: 8.822

3.  Targeting the trehalose utilization pathways of Mycobacterium tuberculosis.

Authors:  Sandeep Thanna; Steven J Sucheck
Journal:  Medchemcomm       Date:  2015-10-16       Impact factor: 3.597

4.  Ligand-bound Structures and Site-directed Mutagenesis Identify the Acceptor and Secondary Binding Sites of Streptomyces coelicolor Maltosyltransferase GlgE.

Authors:  Karl Syson; Clare E M Stevenson; Farzana Miah; J Elaine Barclay; Minhong Tang; Andrii Gorelik; Abdul M Rashid; David M Lawson; Stephen Bornemann
Journal:  J Biol Chem       Date:  2016-08-16       Impact factor: 5.157

5.  Synthesis of C7/C8-cyclitols and C7N-aminocyclitols from maltose and X-ray crystal structure of Streptomyces coelicolor GlgEI V279S in a complex with an amylostatin GXG-like derivative.

Authors:  Radhika Thanvi; Thilina D Jayasinghe; Sunayana Kapil; Babatunde Samuel Obadawo; Donald R Ronning; Steven J Sucheck
Journal:  Front Chem       Date:  2022-09-09       Impact factor: 5.545

6.  Synthesis of multiply fluorinated N-acetyl-D-glucosamine and D-galactosamine analogs via the corresponding deoxyfluorinated glucosazide and galactosazide phenyl thioglycosides.

Authors:  Vojtěch Hamala; Lucie Červenková Šťastná; Martin Kurfiřt; Petra Cuřínová; Martin Dračínský; Jindřich Karban
Journal:  Beilstein J Org Chem       Date:  2021-05-11       Impact factor: 2.883

7.  Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors.

Authors:  Jared J Lindenberger; Sri Kumar Veleti; Brittney N Wilson; Steven J Sucheck; Donald R Ronning
Journal:  Sci Rep       Date:  2015-08-06       Impact factor: 4.379

8.  Metabolic Network for the Biosynthesis of Intra- and Extracellular α-Glucans Required for Virulence of Mycobacterium tuberculosis.

Authors:  Hendrik Koliwer-Brandl; Karl Syson; Robert van de Weerd; Govind Chandra; Ben Appelmelk; Marina Alber; Thomas R Ioerger; William R Jacobs; Jeroen Geurtsen; Stephen Bornemann; Rainer Kalscheuer
Journal:  PLoS Pathog       Date:  2016-08-11       Impact factor: 6.823

9.  Structure of Mycobacterium thermoresistibile GlgE defines novel conformational states that contribute to the catalytic mechanism.

Authors:  Vitor Mendes; Michal Blaszczyk; Ana Maranha; Nuno Empadinhas; Tom L Blundell
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

Review 10.  Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge.

Authors:  Partha Karmakar; Vishwanath Gaitonde
Journal:  Medicines (Basel)       Date:  2019-01-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.